A group sequential procedure for interim treatment selection

Statistics in Biopharmaceutical Research

Volumn 3, Issue 1, 2011, Pages 1-13

  Wang, Yining ^a   Lan, K K Gordon ^a   Li, Gang ^a   Ouyang, S Peter ^b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b CELGENE CORPORATION   (United States)

Author keywords

Closure principle; Family wise error rate; Group sequential; Multiple comparison; Spending function

Indexed keywords

ARTICLE; CONTROLLED STUDY; FAMILY WISE ERROR RATE; HUMAN; HYPOTHESIS; NORMAL DISTRIBUTION; SAMPLE SIZE; SEQUENTIAL ANALYSIS; SIMULATION; STATISTICAL PARAMETERS;

EID: 84867128323     PISSN: None     EISSN: 19466315     Source Type: Journal    
DOI: 10.1198/sbr.2011.09051     Document Type: Article

References (23)

1. Dunnett, C.W. (1955), "A Multiple Comparison Procedure for Comparing Several Treatments with a Control, " Journal of the American Statistical Association, 50, 1096-1121. 3, 9
2. Kelly, P., Stallard, N., and Todd, S. (2005), "An Adaptive Group Sequential Design for Phase II/III Clinical Trials that Select a Single Treatment from Several, " Journal of Biopharmaceutical Statistics, 15, 641-658. 1
3. Koenig, F., Brannath, W., Bretz, F., and Posch, M. (2008), "Adaptive Dunnett Tests for Treatment Selection, " Statistics in Medicine, 27, 1612-1625. 1
4. Lan, K.K.G., and DeMets, D.L. (1989), "Group Sequential Procedures: Calendar Versus Information Time, " Statistics in Medicine, 8, 1191-1198. 4, 12
5. Lan, K.K.G., and DeMets, D.L. (2009), "Further Comments on the Alpha-Spending Function, " Statistics in Biosciences, 1, 95-111. DOI 10.1007/s 12561-0099004-3. 4
6. Lan, K.K.G., and Lachin, J.M. (1990), "Implementation of Group Sequential Logrank Tests in a Maximum Duration Trial, " Biometrics, 46, 759-770. 12
7. Lan, K.K.G., Soo, Y., and Shun, Z. (2005), "Normal Approximation for Two-Stage Winner Design, " in Random Walks, Sequential Analysis and Related Topics, eds. A.C. Hsiung, Z. Ying, and C.H. Zhang, Singapore: World Scientific, pp. 28-43. 1
8. Li, G., Shao, P.Y.S., and Wang, Y. (2001), "Test of a Normal Mean Vector with Hypotheses Determined by Linear Inequalities, " Journal of Statistical Computation and Simulation, 70, 289-298. 5
9. Li, G., Wang, Y., and Ouyang, S.P. (2009), "Interim Treatment Selection in Drug Development, " Statistics in BioSciences, 1, 268-288, DOI 10.1007/s12561-009-9017-y. 1, 5
10. Li, G., Zhu, Z., Ouyang, S.P., Xie, J., Deng, L., and Law, G. (2009), "Adaptive Designs for Interim Dose Selection, " Statistics in Pharmaceutical Research, 1, 366-376. 1
11. Liu, Q., and Pledger, G.W. (2005), "Phase 2 and 3 Combination Designs to Accelerate Drug Development, " Journal of the American Statistical Association, 100, 493-536. 1
12. Marcus, R., Peritz, E., and Gabriel, K. R. (1976), "On Closed Testing Procedures with Special Reference to Ordered Analysis of Variance, " Biometrika, 63, 655-660. 8
13. Proschan, M. A. (1999), "Statistical Methods for Monitoring Clinical Trials, " Journal of Biopharmaceutical Statistics, 9, 599-615. 4
14. Proschan, M.A., Lan, K.K., and Wittes, J.T. (2006), Statistical Monitoring of Clinical Trials: A Unified Approach, New York: Springer. 11
15. Sampson, A.R., and Sill, M.W. (2005), "Drop-the-Losers Design: Normal Case, " Biometrical Journal, 47, 257-268. 1
16. Shun, Z., Lan, K.K.G., and Soo, Y. (2008), "Interim Treatment Selection Using the Normal Approximation Approach in Clinical Trials, " Statistics in Medicine, 27, 597-618. 1
17. Sill, M.W. (2000), "Estimation and Inference for Drop-the-Losers Designs, " unpublished Ph.D. Dissertation, Department of Statistics, University of Pittsburgh, PA. 1
18. Stallard, N., and Friede, T. (2008), "A Group-Sequential Design for Clinical Trials with Treatment Selection, " Statistics in Medicine, 27, 6209-6227. 2, 4
19. Stallard, N., and Todd, S. (2003), "Sequential Designs for Phase III Clinical Trials Incorporating Treatment Selection, " Statistics in Medicine, 22, 689-703. 1
20. Thall, P.F., Simon, R., and Ellenberg, S.S. (1988), "Two-Stage Selection and Testing Designs for Comparative Clinical Trials, " Biometrika, 75, 303-310. 1
21. Thall, P.F., Simon, R., and Ellenberg, S.S. (1989), "A Two-Stage Design for Choosing Among Several Experimental Treatments and a Control in Clinical Trials" Biometrics, 45, 537-547. 1
22. Todd, S., and Stallard, N. (2005), "A New Clinical Trial Design Combining Phases 2 and 3: Sequential Designs with Treatment Selection and aChange of Endpoint, " Drug Information Journal, 39, 109-118. 1
23. Whitehead, J. (1986), "Sample Size for Phase 2 and Phase III Clinical Trials, " Statistics in Medicine, 5, 459-464. 1